About 300 reports

Abstract: What`s New for 2022? -Global competitiveness and key competitor percentage market shares -Market presence across multiple geographies - Strong/Active/Niche/Trivial -Online interactive peer-to-peer collaborative bespoke updates -Access to our digital archives and MarketGlass...

  • Gene Therapy
  • World

The Gene Therapy Market was estimated to be USD 4,118.31 million in 2021 and is poised to grow at a CAGR of 25.71% by 2027 to reach USD 14,824.97 million. The COVID-19 pandemic is expected to have a positive effect on the gene therapy market. Gene and cell therapy technology are expected to be extensively used in the development of...

  • Gene Therapy
  • World
  • Health Expenditure
  • Cancer Incidence

In-depth Analysis and Data-driven Insights on the Impact of COVID-19 Included in this U.S. Gene Therapy Market Report The market is witnessing steady growth due to the increased availability of funding from various public and private institutes. In addition, there is increased support from regulatory bodies for product approvals and...

  • Gene Therapy
  • United States
  • Drug Approval
  • Cancer Incidence

In-depth Analysis and Data-driven Insights on the Impact of COVID-19 Included in this Global Cell and Gene Therapy Market Report The cell and gene therapy market size was valued at USD 4.99 billion in 2021 and is expected to reach USD 36.92 billion by 2027, growing at a CAGR of 39.62 % during the forecast period The following...

  • Gene Therapy
  • World
  • Cancer Incidence
  • Drug Approval

Report Scope: The current report provides detailed exposure to the cell and gene therapy market.This report also highlights the current and future market potential of CGTs along with a detailed analysis of the drivers, restraints, and opportunities in the market. The report also covers market projections to 2026...

  • Gene Therapy
  • World
  • APAC
  • Drug Approval

Global Gene Therapy Market 2022-2026 The analyst has been monitoring the gene therapy market and it is poised to grow by $ 4.02 bn during 2022-2026 progressing at a CAGR of 19.84% during the forecast period. Our report on the gene therapy market provides a holistic analysis, market size and forecast, trends, growth drivers,...

  • Gene Therapy
  • World

Major players in the gene therapy market are Novartis AG, Bluebird Bio Inc., Spark Therapeutics Inc., Audentes Therapeutics, Voyager Therapeutics, Applied Genetic Technologies Corporation, UniQure N.V., Celgene Corporation, Cellectis S.A. and Sangamo Therapeutics. The global gene therapy market is expected to grow from $3.18 billion...

  • Gene Therapy
  • World
  • United States
  • United Kingdom
  • Cancer Incidence
  • Cancer Mortality

Asia-Pacific Gene Therapy Market The main driving factors for the Asia-Pacific gene therapy market are the growing gene therapy development and clinical trial activity, rising prevalence of chronic diseases, strategic developments among market players, and public and private initiatives to raise awareness on this issue....

  • Gene Therapy
  • APAC
  • Chronic Disease Prevalence

Abstract: - Global Cancer Gene Therapy Market to Reach $3.8 Billion by 2027 - Amid the COVID-19 crisis, the global market for Cancer Gene Therapy estimated at US$611.9 Million in the year 2020, is projected to reach a revised size of US$3.8 Billion by 2027, growing at a CAGR of 29.6% over the analysis period 2020-2027....

  • Gene Therapy
  • World
  • China
  • United States

Abstract: - Global Hemophilia Gene Therapy Market to Reach $15.8 Billion by 2027 - Amid the COVID-19 crisis, the global market for Hemophilia Gene Therapy estimated at US$12.2 Billion in the year 2020, is projected to reach a revised size of US$15.8 Billion by 2027, growing at a CAGR of 3.8% over the analysis period...

  • Blood Disease
  • Gene Therapy
  • World
  • China
  • United States

Nucleic Acid Based Gene Therapy Global Market Opportunities And Strategies To 2030: COVID-19 Growth and Change provides the strategists; marketers and senior management with the critical information they need to assess the global nucleic acid based gene therapy market as it emerges from the COVID 19 shut down. Description: Where...

  • Gene Therapy
  • World
  • Health Expenditure
  • Gross Domestic Product Per Capita

In-depth Analysis and Data-driven Insights on the Impact of COVID-19 Included in this Europe Cell and Gene Therapy Market Report The Europe cell and gene therapy market by revenue is expected to grow at a CAGR of over 23% during the period 2021–2026. The global cell and gene therapy market is observing significant mergers and...

  • Gene Therapy
  • Europe
  • Health Expenditure
  • Surgical Procedures Performed

The global viral vector and plasmid DNA manufacturing market was valued at USD 591.29 million in 2020, and it is expected to reach USD 2,244.29 million by 2026, registering a CAGR of 23.38 %, during the period of 2021-2026. COVID-19 is expected to have a positive effect on the Viral Vector and Plasmid DNA Manufacturing Market. Several...

  • Gene Therapy
  • Healthcare
  • World
  • Europe
  • North America
  • APAC
  • Health Expenditure
  • Cancer Incidence

Cell and Gene Therapy Market Opportunities And Strategies To 2030: COVID-19 Growth And Change provides the strategists, marketers and senior management with the critical information they need to assess the global cell and gene therapy market as it emerges from the COVID 19 shut down. Description: Where is the largest...

  • Gene Therapy
  • World
  • APAC
  • Health Expenditure
  • Gross Domestic Product Per Capita

The global cell & gene therapy manufacturing services market size is projected to reach USD 13.8 billion by 2026 from USD 7.7billion in 2021, at a CAGR of 12.4% during the forecast period. Growth in this market is primarily driven by the high incidence of cancer and other target diseases, increasing investments in pharmaceutical R&D, investments...

  • Gene Therapy
  • World
  • Europe
  • North America
  • APAC
  • Cancer Incidence
  • Pharmaceutical R&D Expenditure

Frataxin Mitochondrial (Friedreich Ataxia Protein or FXN or EC 1.16.3.1) - Drugs In Development, 2021 Summary Frataxin Mitochondrial (Friedreich Ataxia Protein or FXN or EC 1.16.3.1) - Frataxin is a protein encoded by the FXN gene. It promotes the biosynthesis of heme and assembly and repair of iron-sulfur...

  • Therapy
  • Dementia
  • Gene Therapy
  • World
  • Energy Supply
  • Medical Technology Density

Outlook for Viral Vector Contract Manufacturing - Gene Therapies, Cell Therapies, and COVID-19 Vaccines Summary This report is the companion to Gene Therapy Market Opportunity for CMOs - 2019 Edition and Cell Therapy Market Opportunity for CMOs - 2018 Edition reports, which described the demand and...

  • Gene Therapy
  • Cell Therapy
  • World
  • United Kingdom
  • Drug Approval
  • Prescription Drug Sales

The Viral Vector Manufacturing Market was estimated to be USD 601.36 million in 2020 and is poised to grow at a CAGR of 27.36% by 2026 to reach USD 2,579.85 million. The COVID-19 pandemic has underlined the importance of vaccine development for the global population. According to the World Health Organisation (WHO), around 151 vaccine...

  • Gene Therapy
  • Healthcare
  • World
  • Europe
  • North America
  • APAC
  • Health Expenditure
  • Cancer Incidence

Major players in the cell and gene therapy market are Gilead Sciences, Bristol-Myers Squibb, Novartis AG, Amgen, Merck, Organogenesis Holdings, Dendreon, Vericel, Bluebird Bio and Fibrocell Science. The global cell and gene therapy market is expected to grow from $6.58 billion in 2021 to $8.57 billion in 2022 at a compound annual growth...

  • Gene Therapy
  • World
  • Western Europe
  • APAC

Executive Summary Global Gene Therapy Market was valued at USD 1221.84 Million in the year 2019. Escalating number of cases related to various chronic diseases including Cancer, Cardiovascular and Neurological Disorders, Alzheimer’s and Sickle Cell Diseases, with companies investing heavily in incorporating advanced technology...

  • Gene Therapy
  • World
  • Dementia Prevalence
  • Schizophrenia Prevalence

The global viral vector & plasmid DNA manufacturing market is expected to reach US$ US$ 2,247.7 million by 2027 from US$ 459.4 million in 2019. The market is estimated to grow with a CAGR of 22.1% from 2020 to 2027. Driving factors such as growing awareness of gene therapy, increasing prevalence of genetic disorders and infectious diseases...

  • Gene Therapy
  • APAC
  • North America
  • Health Expenditure
  • Chronic Disease Prevalence

The Global Gene Therapy Partnering Agreements 2010-2021 report provides an understanding and access to the gene therapy partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in gene therapy partnering deals Disclosed headlines, upfronts, milestones and royalties by stage...

  • Gene Therapy
  • World

The This research service discusses the cell and gene therapy (CGT) market and highlights some key roadblocks in viral vector manufacturing.While many CGT candidates exist in the pipeline, there is a huge capacity deficit that the industry is collaboratively trying to address. Scalability, costs, reproducibility, and overall process...

  • Gene Therapy

Gene Therapy market is one of the high-growth prospect industries with potential opportunities throughout 2028. The Gene Therapy Market growth analysis and insights report analyzes emerging market trends, market size outlook, potential opportunities, market share by Gene Therapy types, applications. Further, Gene Therapy market size is forecast...

  • Gene Therapy
  • World

Hepatocyte Growth Factor - Drugs In Development, 2021 Summary Hepatocyte Growth Factor (Hepatopoietin A or Scatter Factor or HGF) - Hepatocyte growth factor (HGF) is a paracrine cellular growth and morphogenic factor secreted by mesenchymal cells and stimulates epithelial cell proliferation, motility,...

  • Pharmaceutical
  • Gene Therapy
  • Cell Therapy
  • World
  • China
  • Drug Approval
  • Mortality Rate

Forecasts by Disease (Cancer, Rare Diseases (Oncologic, Non-Oncologic), Cardiovascular Diseases, Ophthalmic Diseases, Hematology, Neurological, Diabetes Mellitus, Other Diseases), by Vector (Viral (Retrovirus, Adenovirus, AAV, Lentivirus, Others), Non-Viral (Naked DNA, Gene Gun, Electroporation, Lipofection)), by Techniques (Gene Augmentation...

  • Gene Therapy
  • Research And Development
  • World
  • APAC

Global Cell & Gene Therapy Cold Chain Logistics Market, By Component (Cryogenic Shippers, Cryogenic Storage Freezers, Ultra Low Freezers, Cold Chain Management Systems, Shipment and Storage Medium, Cryogenic Packout Kits, Others), By Services Offered (Transportation, Storage, Packaging) By Mode of Transportation (Air, Ground, Water),...

  • Cold Chain
  • Logistics
  • Gene Therapy
  • World
  • Drug Approval

Global Cancer Gene Therapy Market 2021-2025 The analyst has been monitoring the cancer gene therapy market and it is poised to grow by $ 2.96 bn during 2021-2025 progressing at a CAGR of 20% during the forecast period. Our report on cancer gene therapy market provides a holistic analysis, market size and forecast, trends,...

  • Gene Therapy
  • World

INTRODUCTION Given the various advantages of cell and gene therapies and their ability to address the underlying causes of serious clinical conditions, the preference for such therapeutic modalities has increased over the years. As a result, several cell and gene therapies have been developed and approved for the treatment...

  • Gene Therapy
  • World
  • APAC

Fanconi Anemia - Pipeline Review, H2 2020 Summary latest Pharmaceutical and Healthcare disease pipeline guide Fanconi Anemia - Pipeline Review, H2 2020, provides an overview of the Fanconi Anemia (Hematological Disorders) pipeline landscape. Fanconi anemia or FA, is a rare, inherited...

  • Therapy
  • Pharmaceutical
  • Blood Disease
  • Gene Therapy
  • World
  • Pharmaceutical Registrations
  • Stem Cell Transplantation